NCT07069699
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07069699
Title Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care RECRUITING Irvine California 92612 United States Details
UC Irvine Health/Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
University of Kansas Clinical Research Center RECRUITING Fairway Kansas 66205 United States Details
University of Kansas Cancer Center RECRUITING Kansas City Kansas 66160 United States Details
University of Kansas Hospital-Indian Creek Campus RECRUITING Overland Park Kansas 66211 United States Details
University of Kansas Hospital-Westwood Cancer Center RECRUITING Westwood Kansas 66205 United States Details
University of Oklahoma Health Sciences Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field